4th Quarter - Report

THE NICKLES GROUP, LLC for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

NDAA - provisions related to biological and chemical defense.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE

Health Issues HCR

Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE

Disaster Planning/Emergencies DIS

Monitored issues related to the material threat list.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP)

Budget/Appropriations BUD

Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and COVID-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.